Tatva Chintan Pharma Chem543321Specialty chemicals
Tatva Chintan Pharma rose on good numbers and is holding up even in a weak market; a guest said the trend is positive and gave a hold call
By ScoutQuest · · 1 min read
- Stop loss level
- 1830
Heard on business television between 12:34:39 - 12:37:39 IST.
- Stock reported good numbers and held up despite a weak broader market.
- Deven Mehta of IDBI Capital said the trend is positive and the stock is holding above its 20-day exponential moving average.
- He suggested keeping a stop loss slightly below the 20-day EMA, around 1830, and holding the counter.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Tatva Chintan Pharma Chem
Tatva Chintan Pharma shares fell about 10% to their lowest level in 23 sessions
22 Oct 2026
Updated Investor Presentation: H1FY27 RoE revised to 6.3%, Debt to EBITDA to 1.16
19 Oct 2026
Tatva Chintan Q2FY27 revenue up 76% YoY to ₹2,173 Mn, PAT up 116%
19 Oct 2026
Source: Live TV News Channel · 21 Oct 2026
The call above is Deven Mehta, IDBI Capital's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.